These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15867863)

  • 1. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease.
    Pott GB; Palmer BE; Sullivan AK; Silviera L; Maier LA; Newman LS; Kotzin BL; Fontenot AP
    J Allergy Clin Immunol; 2005 May; 115(5):1036-42. PubMed ID: 15867863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
    Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
    J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production.
    Dobis DR; Sawyer RT; Gillespie MM; Newman LS; Maier LA; Day BJ
    Am J Respir Cell Mol Biol; 2010 Oct; 43(4):458-64. PubMed ID: 19901345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
    J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?
    Heldt GH; Deubner DC
    Inhal Toxicol; 2015; 27(5):262-71. PubMed ID: 25942054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease.
    Palmer BE; Mack DG; Martin AK; Gillespie M; Mroz MM; Maier LA; Fontenot AP
    J Immunol; 2008 Feb; 180(4):2704-12. PubMed ID: 18250483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression.
    Martin AK; Mack DG; Falta MT; Mroz MM; Newman LS; Maier LA; Fontenot AP
    J Allergy Clin Immunol; 2011 Nov; 128(5):1100-6.e1-5. PubMed ID: 21943943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.
    Chain JL; Martin AK; Mack DG; Maier LA; Palmer BE; Fontenot AP
    J Immunol; 2013 Aug; 191(4):1648-56. PubMed ID: 23851684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA; Kittle LA; Mroz MM; Newman LS
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
    Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
    Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum angiotensin converting enzyme activity in chronic beryllium disease.
    Newman LS; Orton R; Kreiss K
    Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease.
    Li L; Hamzeh N; Gillespie M; Elliott J; Wang J; Gottschall EB; Mroz PM; Maier LA
    PLoS One; 2015; 10(2):e0117276. PubMed ID: 25689051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9 and IL-1R1 Promote Mobilization of Pulmonary Dendritic Cells during Beryllium Sensitization.
    Wade MF; Collins MK; Richards D; Mack DG; Martin AK; Dinarello CA; Fontenot AP; McKee AS
    J Immunol; 2018 Oct; 201(8):2232-2243. PubMed ID: 30185516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of pathogenic T cells in patients with beryllium-induced lung disease.
    Fontenot AP; Falta MT; Freed BM; Newman LS; Kotzin BL
    J Immunol; 1999 Jul; 163(2):1019-26. PubMed ID: 10395700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
    J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.